Drugmakers are looking at all options for a possible therapeutic for COVID-19 as the novel coronavirus pandemic continues its spread. One area with some promise? HIV meds––but one drugmaker is tamping ...

-- Two Companies to Also Collaborate On the Further Development of Complera®, Marketed As Eviplera® In The European Union -- Cork, Ireland, 29 December 2014 - Janssen R&D Ireland (Janssen) announced ...

Johnson & Johnson JNJ subsidiary, Janssen Therapeutics announced that it has submitted a marketing authorization to the European Medicines Agency for a once-daily single tablet regimen (STR) ...

BRIDGEWATER, N.J., Feb. 11 Tibotec Therapeutics, a division of Centocor Ortho Biotech Products, L.P., today announced the availability of a lower-dose (75 mg) formulation of PREZISTA (darunavir) for ...

Camber is offering darunavir tablets, which is the generic of Janssen's Prezista. Darunavir tablets are a human immunodeficiency virus protease inhibitor indicated for the treatment of HIV-1 infection ...

Prezista bottle Janssen Therapeutics announced that the Food and Drug Administration (FDA) has expanded the use of Prezista (darunavir) in pregnant women with HIV infection. Janssen Therapeutics ...

NEW YORK (Reuters) - Johnson & Johnson said on Tuesday its drug Prezista was as effective in a late-stage trial as Abbott Laboratories Inc's Kaletra in cutting HIV to undetectable levels among ...

The Texas Attorney General announced an investigation into StubHub Inc on Friday, amid dozens of complaints that World Cup tickets purchased on the resale platform were never delivered. Reuters, the ...

With Gift Aid, your generous donation of £10 would be worth £12.50 at no extra cost to you. Yes, I want to Gift Aid any donations made to NAM now, in the future and in the past four years I am a UK ...

With Gift Aid, your generous donation of £10 would be worth £12.50 at no extra cost to you. Yes, I want to Gift Aid any donations made to NAM now, in the future and in the past four years I am a UK ...

February 21, 2007 — The European Commission (EC) has granted conditional approval for darunavir ethanolate, allowing its use with ritonavir and other antiretroviral drugs in the treatment of ...

To earn CME related to this news article, click here. January 21, 2009 — The US Food and Drug Administration (FDA) has approved safety labeling revisions to advise of the potential for ...